Covid-19: Considerations For Rheumatologists

COVID-19: Considerations for Rheumatologists

The Immune-Mediated Inflammatory Disease Forum

Rheumatology: COVID-19 implications for lungs & fibrosis - parallels with diffuse systemic sclerosis

Royal Society of Medicine

Rheumatology and Rehabilitation: COVID-19 and the use of rheumatology drugs

Royal Society of Medicine

COVID-19 and Rheumatology

AlbertaRheumatology

How has COVID-19 Affected Your Rheumatology Practice? - Virginia Reddy, MD

American College of Rheumatology

COVID-19 Global Rheumatology Alliance

American College of Rheumatology

Daniel Albert, MD: Telemedicine Challenges for Rheumatologists During COVID-19

COVID-19 Global Rheumatology Alliance Big Start

COVID-19 Q&A Webinar

British Society for Rheumatology

ACR Issues COVID-19 Treatment Guidance for Rheumatic Disease Patients

Rheumatology Network MJH Life Sciences

COVID-19 and Rheumatologists/Clinical Immunologists

ClevelandClinicCME

12-3-20 - COVID-19: A Rheumatologist’s Perspective

WashU Medicine Department of Medicine

Dr. Diane Lacaille - COVID-19 Global Rheumatology Alliance

Arthritis Research Canada

ACR and COVID-19 Update: Our Response and Resources for You

American College of Rheumatology

The COVID-19 Global Rheumatology Alliance registry: What you need to know | Philip Robinson

Medicine Matters rheumatology

Covid19 Discussion with Rheumatologist Dr. Nickolas Tyris

Contagion Live News Network: COVID-19 Outbreak Impacts Rheumatology Research

COVID-19 Update for Patients with Autoimmune Disease: Rheumatology Perspective

Emory Department of Medicine

A Rheumatologist's message to immunosuppressed patients

Rheumatology & Rehabilitation: Common therapeutic pathways - the cytokine storm in COVID-19

Royal Society of Medicine